Related Experiment Video
Updated: Aug 13, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
RNA Interference Approach Is a Good Strategy against SARS-CoV-2
Ying-Ray Lee1,2,3,4, Huey-Pin Tsai5,6, Chun-Sheng Yeh6
1Department of Microbiology and Immunology, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Small interfering RNA (siRNA) therapy shows promise for treating COVID-19 by suppressing SARS-CoV-2 replication. This RNA interference approach targets key viral proteins, offering a potential new therapeutic strategy pending clinical trials.
Area of Science:
- Molecular Biology
- Virology
- Biotechnology
Background:
- COVID-19, caused by SARS-CoV-2, remains a global health crisis with no targeted treatments.
- Current vaccines show unsatisfactory protection due to SARS-CoV-2's genetic complexity and high mutation rate.
Purpose of the Study:
- To investigate the potential of small interfering RNA (siRNA) therapeutics against SARS-CoV-2.
- To design and evaluate shRNAs targeting conserved regions of SARS-CoV-2 for replication suppression.
Main Methods:
- Design of short hairpin RNAs (shRNAs) targeting RNA-dependent RNA polymerase (RdRP) and spike proteins of SARS-CoV-2.
- Assessment of shRNA efficacy in suppressing viral replication through post-transcriptional gene silencing.
Main Results:
- Developed two highly effective shRNAs demonstrating significant suppression of SARS-CoV-2 replication.
- The shRNA strategy leverages RNA interference for targeted gene silencing.
Conclusions:
- shRNA-based therapy presents a promising strategy for combating COVID-19.
- Further clinical trials are necessary to validate the therapeutic potential of this approach.
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
The Antiviral System of Bacteria and Archaea: CRISPR
Viruses with RNA Genomes

